Case studies: Orthopaedic surgery in adult patients with haemophilia A with inhibitors

Haemophilia, Supplement

Volumn 11, Issue 1, 2005, Pages 32-37

  Goddard, Nicholas ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Arthropathy; Haemophilia; Haemostasis; Inhibitors; Orthopaedic surgery; Recombinant activated factor VII

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; ANTIFIBRINOLYTIC AGENT; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 ANTIBODY; BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 9; BLOOD CLOTTING FACTOR 9 CONCENTRATE; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ANTIBODY PRODUCTION; ARTHROPATHY; ARTICLE; BLEEDING; BOLUS INJECTION; COST EFFECTIVENESS ANALYSIS; DRUG MEGADOSE; FOLLOW UP; HEMOPHILIA A; HEMOSTASIS; HUMAN; LONG TERM CARE; OPTIMAL DRUG DOSE; ORTHOPEDIC SURGERY; POSTOPERATIVE CARE; PRIORITY JOURNAL; SYNOVECTOMY; THROMBOSIS; TREATMENT OUTCOME;

EID: 27744440528     PISSN: 13550691     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2005.01155.x     Document Type: Article

References (30)

1. Insall JN, Dorr LD, Scott RD, Scott WN. Rationale of the Knee Society clinical rating system. Clin Orthop Relat Res 1989; 248: 13-4.
2. Harris WH. Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. J Bone Joint Surg [Br] 1969; 51: 737-55.
3. Constant CR, Murley AHG. A clinical method of functional assessment of the shoulder. Clin Orthop Relat Res 1987; 214: 160-4.
4. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988; 15: 1833-40.
5. Dawson J, Fitzpatrick R, Carr A. Questionnaire on the perceptions of patients about shoulder surgery. J Bone Joint Surg [Br] 1996; 78: 593-600.
6. Dawson J, Fitzpatrick R, Carr A, Murray D. Questionnaire on the perceptions of patients about total hip replacement. J Bone Joint Surg [Br] 1996; 78: 185-90.
7. Dawson J, Fitzpatrick R, Murray D, Carr A. Questionnaire on the perceptions of patients about total knee replacement. J Bone Joint Surg [Br] 1998; 80: 63-69.
8. Pettersson H, Gilbert MS. Clinical and radiological evaluations of hemophilic arthropathy. In: Pettersson H, Gilbert MS, eds. Diagnostic Imaging in Hemophilia. Berlin: Springer-Verlag, 1985: 56-68.
9. Rizza CR, Spooner RJD, Giangrande PLF, on behalf of the UK Haemophilia Centre Doctors' Organization (UKHCDO). Treatment of haemophilia in the United Kingdom 1981-1996. Haemophilia 2001; 7: 349-59.
10. Biggs R. Jaundice and antibodies directed against factors VIII and IX in patients treated for haemophilia or Christmas disease in the United Kingdom (on behalf of the Directors of 37 Haemophilia Centres in the United Kingdom). Br J Haematol 1974; 26: 313-29.
11. Rodriguez-Merchan EC, Wiedel JD, Wallny T et al. Elective orthopaedic surgery for inhibitor patients. Haemophilia 2003; 9: 625-31.
12. Oldenburg J, El-Maarri O, Schwaab R. Inhibitor development in correlation to factor VIII genotypes. Haemophilia 2002; 8(Suppl. 2): 23-29.
13. Oldenburg J, Picard JK, Schwaab R, Brackmann HH, Tuddenham EG, Simpson E. HLA genotype of patients with severe haemophilia A due to intron 22 inversion with and without inhibitors of factor VIII. Thromb Haemost 1997; 77: 238-42.
14. Scharrer I, Bray GL, Neutzling O. Incidence of inhibitors in haemophilia A patients - a review of recent studies of recombinant and plasma-derived factor VIII concentrates. Haemophilia 1999; 5: 145-54.
15. Gill FM. The natural history of factor VIII inhibitors in patients with hemophilia A. Prog Clin Biol Res 1984; 150: 19-29.
16. Astermark J, Berntorp E, White GC, Kroner BL, MIBS Study Group. The Malmo International Brother Study (MIBS): further support for genetic predisposition to inhibitor development in hemophilia patients. Haemophilia 2001; 7: 267-72.
17. Peerlinck K, Arnout J, Gilles JG, Saint-Remy JM, Vermylen J. A higher than expected incidence of factor VIII inhibitors in multitransfused haemophilia A patients treated with an intermediate purity pasteurized factor VIII concentrate. Thromb Haemost 1993; 69: 115-8.
18. Peerlinck K, Arnout J, Di Giambattista M et al. Factor VIII inhibitors in previously treated haemophilia A patients with a double virus-inactivated plasma derived factor VIII concentrate. Thromb Haemost 1997; 77: 80-6.
19. Sharathkumar A, Lillicrap D, Blanchette VS, Kern M, Leggo J, Stain AM. Intensive exposure to factor VIII is a risk factor for inhibitor development in mild hemophilia A. J Thromb Haemost 2003; 1: 1228-36.
20. Wight J, Paisley S. The epidemiology of inhibitors in haemophilia A: a systematic review. Haemophilia 2003; 9: 418-35.
21. Hvid I, Rodriguez-Merchan EC. Orthopaedic surgery in haemophilia patients with inhibitors: an overview. Haemophilia 2002; 8: 288-91.
22. Hedner U, Glazer S, Pingel K et al. Successful use of recombinant factor VIIa in patient with severe haemophilia A during synovectomy. Lancet 1988; 2: 1193.
23. Schulman S, Lindstedt M, Alberts KA, Agren PH. Recombinant factor VIIa in a multiple surgery (letter). Thromb Haemost 1994; 41: 154.
24. O'Marcaigh AS, Schmalz BJ, Shaughnessy WJ, Gilchrist GS. Successful hemostasis during a major orthopedic operation by using recombinant activated factor VII in a patient with severe hemophilia A and a potent inhibitor. Mayo Clin Proc 1994; 69: 641-4.
25. Ingerslev J, Freidman D, Gastineau D et al. Major surgery in haemophiliac patients with inhibitors using recombinant factor VIIa. Haemostasis 1996; 26(Suppl. 1): 118-23.
26. Schulman S, Bech Jensen M, Varon D et al. Feasibility of using recombinant factor VIIa in continuous infusion. Thromb Haemost 1996; 75: 432-6.
27. Schulman S, d'Oiron R, Martinowitz U et al. Experiences with continuous infusion of recombinant activated factor VII. Blood Coagul Fibrinolysis 1998; 9(Suppl. 1): S97-101.
28. Shapiro AM, Gilchrist GS, Hoots K, Copper H, Gastineau D. Prospective, randomised trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgery. Thromb Haemost 1998; 80: 773-8.
29. Rodriguez-Merchan EC, de la Corte H. Orthopaedic surgery in haemophiliac patients with inhibitors: a review of the literature. In: Rodriguez-Merchan EC, Goddard NJ, Lee CA, eds. Musculoskeletal Aspects of Haemophilia. Oxford: Blackwell, 2000: 136-42.
30. Tagariello G, Bisson R, Radossi P et al. Concurrent total hip and knee replacements in a patient with haemophilia with inhibitors using recombinant factor VIIa by continuous infusion. Haemophilia 2003; 9: 738-40.